Pembrolizumab and Olaparib in Cervical Cancer Patients

NCT04483544 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Poor accrual related to change in standard of care treatment for this population.

Conditions

Cervical Cancer
Cervical Carcinoma

Interventions

DRUG: pembrolizumab
DRUG: olaparib

Sponsor

Baptist Health South Florida

Collaborators

[object Object]
[object Object]